Tag: VEITH Symposium
Xeltis announces US FDA Breakthrough Device Designation for aXess and first...
Xeltis has today announced that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has granted aXess...
Renal Interventions’ top 10 stories of November 2023
November was a month of demands for more vascular access (VA) training, novel technologies, and regulations, with Terry Litchfield highlighting the importance of compliance...